| William R Kogl, CRNA | |
|
400 N Mills Ave, Orlando, FL 32803-5722 | |
| (407) 872-2244 | |
| (407) 926-9173 |
| Full Name | William R Kogl |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 400 N Mills Ave, Orlando, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023039666 | NPI | - | NPPES |
| G3815 | Other | FL | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | ARNP3272472 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William R Kogl, CRNA 200 Page St, Orlando, FL 32806-3051 Ph: (407) 649-7873 | William R Kogl, CRNA 400 N Mills Ave, Orlando, FL 32803-5722 Ph: (407) 872-2244 |
News Archive
Global healthcare consulting revenues passed US$10bn in 2018, with the market growing 9.1% as healthcare companies pursued a global agenda of growth, efficiency, patient-centricity, and digitization. This excellent growth rate outpaced even 2017's strong 8% growth.
The Icahn School of Medicine at Mount Sinai has been awarded nearly $1.7 million in grant funding from the U.S. Department of Defense to study how bladder cancer affects certain types of white blood cells called "natural killer" cells, or NK cells, which control and limit tumor growth.
Shortening end caps on chromosomes in human cervical cancer cells disrupts DNA repair signaling, increases the cells' sensitivity to radiation treatment and kills them more quickly, according to a study in Cancer Prevention Research.
ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration to market its second-generation Parallax Contour -enhanced Vertebral Augmentation Device specifically for void creation in a vertebral body followed by injection of bone cement.
Cipher Pharmaceuticals Inc. today provided top-line safety and efficacy results from the Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin for the treatment of severe, nodular acne.
› Verified 1 days ago
Danielle Larson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 601 E Rollins St, Orlando, FL 32803 Phone: 407-667-0444 Fax: 407-667-4338 | |
Mary Amber Davis, RN Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 27 Wintergreen Way, Orlando, FL 32825 Phone: 386-216-8994 | |
Darmela Shannon Thornton, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 601 E Rollins St, Orlando, FL 32803 Phone: 407-303-5600 | |
Stacey L. Bettes, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 225 E Robinson St, Suite 130, Orlando, FL 32801 Phone: 407-581-9180 Fax: 865-560-7066 | |
Amanda Gabriele Hermida, RN Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 52 W Underwood St, Orlando, FL 32806 Phone: 321-841-5111 | |
Mr. Said Ricardo Acosta, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 13535 Nemours Pkwy, Orlando, FL 32827 Phone: 407-567-4000 Fax: 407-650-7124 |